Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lacticaseibacillus casei AMBR2 modulates the epithelial barrier function and immune response in a donor-derived nasal microbiota manner
Charlotte De Rudder, Cristina García‐Timermans, Ilke De Boeck, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology
Kshitis Chandra Baral, Rajiv Bajracharya, Sang Hoon Lee, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7535-7556
Open Access | Times Cited: 88
Characteristics of Probiotic Preparations and Their Applications
Guangqiang Wang, Yunhui Chen, Yongjun Xia, et al.
Foods (2022) Vol. 11, Iss. 16, pp. 2472-2472
Open Access | Times Cited: 67
Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases
Rong Zhang, Lan Zhang, Peishan Li, et al.
International Archives of Allergy and Immunology (2023) Vol. 184, Iss. 5, pp. 481-501
Open Access | Times Cited: 38
The nasopharyngeal microbiome in COVID-19
Sergio Candel, Sylwia D. Tyrkalska, Carmen Álvarez-Santacruz, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Short-Chain Fatty Acids: Promising Therapeutic Targets for Respiratory Syncytial Virus Infection
Liang Mao, Qiang Dong, Weiyi Wu, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access | Times Cited: 1
Lactic acid bacteria as probiotics for the nose?
Ilke De Boeck, Irina Spacova, Olivier M. Vanderveken, et al.
Microbial Biotechnology (2021) Vol. 14, Iss. 3, pp. 859-869
Open Access | Times Cited: 43
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Fabio Palmieri, Angela Koutsokera, Eric Bernasconi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
Ilke De Boeck, Eline Cauwenberghs, Irina Spacova, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 25
Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections
Irina Spacova, Ilke De Boeck, Eline Cauwenberghs, et al.
Microbial Biotechnology (2022) Vol. 16, Iss. 1, pp. 99-115
Open Access | Times Cited: 25
The role of probiotics in modulating the microbiota of the nose and paranasal sinuses and reducing chronic inflammation of the paranasal sinuses
Jakub Zblewski, Bartosz Kozakiewicz, Krzysztof Dalke, et al.
Polski Przegląd Otorynolaryngologiczny (2025) Vol. 14, Iss. 1, pp. 1-6
Closed Access
Topical Microbial Therapeutics against Respiratory Viral Infections
Irina Spacova, Ilke De Boeck, Peter A. Bron, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 6, pp. 538-553
Open Access | Times Cited: 25
The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms
Ilke De Boeck, Stijn Wittouck, Katleen Martens, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 102978-102978
Open Access | Times Cited: 21
Effects of Probiotic Supplementation during Chronic Rhinosinusitis on the Microbiome
Arkadiusz Standyło, Aleksandra Obuchowska, Anna Horaczyńska-Wojtaś, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1726-1726
Open Access | Times Cited: 1
Insights into respiratory microbiome composition and systemic inflammatory biomarkers of bronchiectasis patients
Aleksandras Konovalovas, Julija Armalytė, Laurita Klimkaitė, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Respiratory syndrome coronavirus‐2 response: Microbiota as lactobacilli could make the difference
Samia Zrelli, Safa Amairia, Malek Zrelli
Journal of Medical Virology (2020) Vol. 93, Iss. 6, pp. 3288-3293
Closed Access | Times Cited: 10
Characterising clinical Staphylococcus aureus isolates from the sinuses of patients with chronic rhinosinusitis
Brett Wagner Mackenzie, Melissa Zoing, Fiona Clow, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
Luca Ferrari, Chiara Favero, Giulia Solazzo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 6
Live biotherapeutic throat spray for respiratory virus inhibition and interferon pathway induction
Irina Spacova, Ilke De Boeck, Eline Cauwenberghs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
The interactions between probiotic bacteria and respiratory viruses within the epithelium of the upper respiratory tract
Tejasri Yarlagadda
(2023)
Open Access
10. LITERATURE REVIEW OF RESEARCH AND DEVELOPMENT OF PROBIOTIC TABLETS
Ngo Nguyen Quynh Anh, Đàm Thanh Xuân, Nguyen Ngoc Chien
Tạp chí Y học Cộng đồng (2023) Vol. 64, Iss. 13
Open Access
Characteristic of upper respiratory tract microbiota in severe covid-19 adult patients in Indonesia
Angky Budianti, Beti Ernawati Dewi, Tjahjani Mirawati Sudiro, et al.
Bali Medical Journal (2023) Vol. 12, Iss. 3, pp. 2366-2372
Open Access
Page 1

Scroll to top